$6M boost to drive industrial-scale Proteomics facility in WA

The center will receive new instrumentation for automatic sampling and set advanced diagnostic workflows to increase innovation in industry, research and medical environments.

It has a precision diagnostic arsenal that is developed from proteomic, proteomic research and supported by the latest predictive platform, aims to meet unmastered needs and expands. The standard protein blood test is located behind the company’s predictive test for diabetic kidney disease, promotereso test for esophageal cancer and promotekerendo for early stage endometriosis.

The tests detect protein biobelizes in a patient’s blood and presents the results as a low, medium or high – universal “traffic light” risk to indicate the possibility of having the disease.

Thanks to a 66 percent subsidiary with UWA, Proteomics developed a revolutionary stress test to monitor muscle damage in elite athletes and purebred racing horses.

Only yesterday, Proteomics announced that it obtained the first patent in Japan with its simple promarkendo Blood test and is preparing for the international commercial output of the product.

Japan is the fourth largest health market in the world and uses in vitro diagnostic and precise drugs to customize the treatments for patients, to provide better patient results and lower clinical costs.

The company completed a capital increase of 12 million dollars at the beginning of the last month through a intensely exaggerated share purchase plan to increase the development and accelerate the launch of four existing diagnostic tests.

The share of sharing came after Proteomics collecting the chests in December last year, and the federal government’s tax promotion program was given a $ 2.16 million research and development grant. The management said that R -Grant will probably be for the test test in the United States Laboratory.

With a number of diagnostic and regulatory applications installed in the basic international judicial zone, proteomics begin to unlock some profitable income flows, while patients, clinicians and the agricultural industry provide potentially changing benefits.

Does your company on the ASX list do something interesting? Contact: Mattbirney@bullsnbears.com.au